Clinical Trial Update: A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing bevacizumab in combination with chemotherapy for osteosarcoma and malignant fibrous histiocytoma of bone has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Fibrous Histiocytoma of Bone
• Osteosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone | Phase 2 | Status: COMPLETED | Results posted: 2014-08-04